Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults

• Main Authors: Tino F. Schwarz (Author), Stephanie Volpe (Author), Gregory Catteau (Author), Roman Chlibek (Author), Marie Pierre David (Author), Jan Hendrik Richardus (Author), Himal Lal (Author), Lidia Oostvogels (Author), Karlis Pauksens (Author), Stephanie Ravault (Author), Lars Rombo (Author), Gerard Sonder (Author), Jan Smetana (Author), Thomas Heineman (Author), Adriana Bastidas (Author)
• Format: Book
• Published: Taylor & Francis Group, 2018-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: In adults aged ≥60 years, two doses of the herpes zoster subunit vaccine (HZ/su; 50 µg varicella-zoster virus glycoprotein E [gE] and AS01B Adjuvant System) elicited humoral and cell-mediated immune responses persisting for at least six years. We assessed immunogenicity nine years post-i...